Susumu Kitamura

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 4

Top Topics

Prognostic Factors

Juvenile Idiopathic Arthritis

Placebo Controlled

Top Venues

The Journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Akimichi Morita, Hidetoshi Takahashi, Kentaro Ozawa, Shinichi Imafuku, Nakama Takekuni, Kenzo Takahashi, Takashi Matsuyama, Yukari Okubo, Yiwei Zhao, Susumu Kitamura, Keiko Takei, Masayuki Yokoyama, Nobukazu Hayashi, Tadashi Terui
Long-term analysis of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa: Open-label phase 3 results. The Journal of dermatology 48 (1) (2020)
Mamitaro Ohtsuki, Hideki Fujita, Mitsunori Watanabe, Keiko Suzaki, Mary Flack, Xin Huang, Susumu Kitamura, Joaquin Valdes, Atsuyuki Igarashi
Efficacy and safety of risankizumab in Japanese patients with moderate to severe plaque psoriasis: Results from the SustaIMM phase 2/3 trial. The Journal of dermatology 46 (8) (2019)
Akimichi Morita, Hidetoshi Takahashi, Kentaro Ozawa, Shinichi Imafuku, Takekuni Nakama, Kenzo Takahashi, Takashi Matsuyama, Yukari Okubo, Susumu Kitamura, Naoto Matsuda, Yiwei Zhao, Masayuki Yokoyama, Nobukazu Hayashi, Tadashi Terui
Twenty-four-week interim analysis from a phase 3 open-label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa. The Journal of dermatology 46 (9) (2019)
Akimichi Morita, Fumikazu Yamazaki, Takashi Matsuyama, Kenzo Takahashi, Satoru Arai, Akihiko Asahina, Shinichi Imafuku, Hidemi Nakagawa, Yuichi Hasegawa, David Williams, Naoto Matsuda, Susumu Kitamura
Adalimumab treatment in Japanese patients with generalized pustular psoriasis: Results of an open-label phase 3 study. The Journal of dermatology 45 (12) (2018)